Vaccine Adjuvants Market Growth, Demand and Challenges of the Key Industry Players 2023-28

1
Global Vaccine Adjuvants Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Vaccine Adjuvants Market Research
Report The latest report by IMARC, titled
Vaccine Adjuvants Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 finds that the global vaccine
adjuvants market size reached US 884 Million in
2022. Vaccine adjuvants are compounds that
improve the bodys immunogenic response against
antigens. They increase the ability of the
vaccines to induce long-term protection against
infections. Presently, aluminum salts and MF59
are the only adjuvants found fit for human use.
In recent years, the demand for vaccine
adjuvants has escalated as they increase antibody
titers, reduce required antigen doses, induce a
rapid immune response and long-lasting memory,
and enhance the immune response in the elderly
and young children. Request Free Sample Report
https//www.imarcgroup.com/vaccine-adjuvants-marke
t/requestsample
4
Report Description and Highlights
Report Description

Global Vaccine Adjuvants Market Trends One of
the primary factors driving the market is the
rising incidences of infectious diseases and
allergies, such as human immunodeficiency virus
(HIV/AIDS), cancer, human papillomavirus (HPV),
and tuberculosis. Additionally, the need for
advanced treatment options for prevailing and
emerging fatal diseases has increased the need to
develop vaccines possessing long-lasting effects
on immunization. Other than this, governments of
numerous nations are taking initiatives for
immunization and improvements in adjuvants for
human consumption. They are also focusing on
enhancing the healthcare infrastructure and
increasing investments in research and
development (RD) of new therapeutics, which is
creating a positive market outlook. Furthermore,
with the sudden coronavirus (COVID-19) outburst,
the demand for effective and safe vaccine
adjuvants is constantly increasing. On account of
these factors, IMARC Group expects the market
value to reach US 1,812 Million by 2028,
expanding at a CAGR of 12.4 during the forecast
period (2023-2028). Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product Type
Adjuvant Emulsions Pathogen Components
Particulate Adjuvants
Combination Adjuvants Others Breakup by
Route of Administration Oral
Intramuscular Intranasal Subc
utaneous Intradermal Others B
reakup by Diseases Cancer Inf
ectious Diseases

6
Report Description and Highlights
Report Description
Others Breakup by Application
Research Commercial Breakup by Region
North America United
States Canada Asia-Pa
cific China Ja
pan India Sout
h Korea Australia
Indonesia Others E
urope Germany

7
Report Description and Highlights
Report Description
France United
Kingdom Italy
Spain Russia O
thers Latin America Br
azil Mexico Ot
hers Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Adjuvance Tecchnologies Inc. Adjuvatis Agenus Inc.
  Brenntag SE Chemtrade Logistics Inc. CSL
  Limited Croda International Plc Invivogen Novavax
  Inc. OZ Biosciences Virometix AG
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/vaccine-adjuvants-marke
  t

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us